CAMRF
Price:
$54.95
Market Cap:
$30.89B
Camurus AB (publ) is a pharmaceutical enterprise dedicated to the development and global commercialization of therapeutic solutions for severe and enduring medical conditions. Its operations span across Europe, Australia, the United States, Japan, and other international markets. Currently available products include Buvidal, a buprenorphine injection designed to manage opioid dependence; episil oral liquid, classified as a medical device for alleviating inflammatory and painful conditions within the oral cavity; and Brixadi, another treatment option for opioid use disorder. Beyond its established offerings, Camurus maintains a robust research and development pipeline featuring several promis...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-12-11
Stock Exchange
OTC
Ticker
CAMRF
According to Camurus AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 45.41. This represents a change of -20.65% compared to the average of 57.23 of the last 4 quarters.
The mean historical PE Ratio of Camurus AB (publ) over the last ten years is 19.14. The current 45.41 PE Ratio has changed 23.62% with respect to the historical average. Over the past ten years (40 quarters), CAMRF's PE Ratio was at its highest in in the June 2022 quarter at 323.80. The PE Ratio was at its lowest in in the March 2022 quarter at -3062.23.
Average
19.14
Median
-11.97
Minimum
-90.79
Maximum
250.39
Discovering the peaks and valleys of Camurus AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 335.39%
Maximum Annual PE Ratio = 250.39
Minimum Annual Increase = -375.80%
Minimum Annual PE Ratio = -90.79
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 49.61 | -35.22% |
| 2024 | 76.57 | 10.69% |
| 2023 | 69.18 | -72.37% |
| 2022 | 250.39 | -375.80% |
| 2021 | -90.79 | 54.65% |
| 2020 | -58.70 | 333.11% |
| 2019 | -13.55 | 30.62% |
| 2018 | -10.38 | -62.11% |
| 2017 | -27.39 | -48.82% |
| 2016 | -53.51 | 335.39% |
The current PE Ratio of Camurus AB (publ) (CAMRF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
65.12
5-year avg
70.99
10-year avg
19.14
Camurus AB (publ)’s PE Ratio is greater than Laboratorios Farmaceuticos Rovi, S.A. (22.52), greater than Santen Pharmaceutical Co., Ltd. (16.37), greater than Genscript Biotech Corporation (-5.88), less than ALK-Abelló A/S (45.70), greater than Ambu A/S (34.95), greater than InnoCare Pharma Limited (21.86), greater than Shanghai Junshi Biosciences Co., Ltd. (-45.62), greater than Telix Pharmaceuticals Limited (-441.49), greater than Livzon Pharmaceutical Group Inc. (13.33), greater than Galapagos N.V. (3.25),
| Company | PE Ratio | Market cap |
|---|---|---|
| 22.52 | $4.63B | |
| 16.37 | $3.54B | |
| -5.88 | $3.50B | |
| 45.70 | $8.18B | |
| 34.95 | $2.56B | |
| 21.86 | $2.32B | |
| -45.62 | $4.84B | |
| -441.49 | $3.26B | |
| 13.33 | $6.06B | |
| 3.25 | $1.85B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Camurus AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Camurus AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Camurus AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Camurus AB (publ) (CAMRF)?
What is the highest PE Ratio for Camurus AB (publ) (CAMRF)?
What is the 3-year average PE Ratio for Camurus AB (publ) (CAMRF)?
What is the 5-year average PE Ratio for Camurus AB (publ) (CAMRF)?
How does the current PE Ratio for Camurus AB (publ) (CAMRF) compare to its historical average?